AffyXell Therapeutics

Japan’s largest R&D hub for bioventures and pharma startups, Shonan Health Innovation Park (Shonan iPark), has been in active talks with Korean bioventures and government groups over the formation of

There is a famous quote by Chinese military strategist and philosopher Sun Tzu that “If you know the enemy and know yourself, you need not fear the result of a hundred battles.” Thierry (Dongkyu) Uh,

UK-based biotech Avacta Group plc plans to action its proprietary Affimer and pre|CISION platforms in a wide range of disease areas – creating products that are easier to manufacture than traditiona

A new joint venture from Avacta Group plc and Daewoong Pharmaceutical Company Ltd. ’s AffyXell Therapeutics has been formed to combine the two firm’s technologies to develop next-generation stem